ClinVar Miner

Submissions for variant NM_001364905.1(LRBA):c.7564A>C (p.Thr2522Pro)

gnomAD frequency: 0.00470  dbSNP: rs62346982
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000544231 SCV000604130 benign Combined immunodeficiency due to LRBA deficiency 2023-10-31 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000544231 SCV000652633 benign Combined immunodeficiency due to LRBA deficiency 2024-01-31 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000508516 SCV000709547 likely benign not specified 2017-06-22 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000659001 SCV000780804 likely benign not provided 2024-08-01 criteria provided, single submitter clinical testing LRBA: BP4, BS2
Mayo Clinic Laboratories, Mayo Clinic RCV000544231 SCV000782749 uncertain significance Combined immunodeficiency due to LRBA deficiency 2017-11-15 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000508516 SCV002071117 likely benign not specified 2020-03-02 criteria provided, single submitter clinical testing
Genetics and Molecular Pathology, SA Pathology RCV000544231 SCV002556590 likely benign Combined immunodeficiency due to LRBA deficiency 2020-08-18 criteria provided, single submitter clinical testing BS1, BP4
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV000544231 SCV003920156 likely benign Combined immunodeficiency due to LRBA deficiency 2022-10-04 criteria provided, single submitter clinical testing This variant has been reported in the literature in 1 individual with panuveitis (Li 2021 PMID:32707200). This variant is present in the Genome Aggregation Database (Highest reported MAF 0.7% (543/67998) (https://gnomad.broadinstitute.org/variant/4-150321257-T-G?dataset=gnomad_r3). This variant is present in ClinVar, with several labs classifying this variant as Likely Benign or Benign (Variation ID:439869). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign.
PreventionGenetics, part of Exact Sciences RCV003925503 SCV004740896 benign LRBA-related disorder 2019-05-10 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.